发明名称 |
CRYSTALLINE FORMS OF (3S)-3-[N-(N-(2-TERT- BUTYLPHENYL)OXAMYL)ALANIWYL]AMINO-5-(2,3,5,6-TETRAFLUORO PHENOXY)-4- 0X0PENTA NOIC ACID (3S)-3-[N-(N-(2-))]-5-(2356- )-4- |
摘要 |
The present invention relates to crystalline forms of (3S)-3-[N—(N′-(2-tert-butylphenyl)oxamyl)alaninyl]amino-5-(2′,3′,5′,6′-tetrafluorophenoxy)-4-oxopentanoic acid (see formula I). The invention further relates to pharmaceutical compositions comprising such crystalline forms and to the use of said pharmaceutical compositions and said crystalline forms in the treatment of various conditions, particularly in the treatment of liver fibrosis. |
申请公布号 |
HK1138567(A1) |
申请公布日期 |
2015.06.26 |
申请号 |
HK20100104322 |
申请日期 |
2010.05.03 |
申请人 |
CONATUS PHARMACEUTICALS INC. |
发明人 |
DIMMOCK, STUART;HAGEN, ERIC;HANKO, JASON |
分类号 |
C07C;A61K;A61P |
主分类号 |
C07C |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|